Carmat SA engages in the developing of implantable orthotropic and biocompatible artificial heart. It also develops electrical power supply system and telediagnostics system. The artificial heart is intended for patients with advanced cardiac insufficiency that is ineligible for a transplant and have exhausted all medication alternatives. It serves patients suffering in the aftermath of a massive heart attack and with late-stage heart failure. Carmat was founded by Pouletty Philippe and Alain Carpentier on June 25, 2008 and is headquartered in VÃ©lizy Villacoublay, France.